Tag Archives: RVSB

Top Performing Stocks For 2021

ValuEngine upgraded shares of Starbucks (NASDAQ:SBUX) from a sell rating to a hold rating in a research note issued to investors on Friday.

Several other research analysts also recently weighed in on the stock. Piper Jaffray Companies downgraded shares of Starbucks from an overweight rating to a neutral rating and set a $72.00 target price on the stock. in a research report on Tuesday, August 21st. Zacks Investment Research raised shares of Starbucks from a strong sell rating to a hold rating in a research report on Tuesday, August 21st. BidaskClub raised shares of Starbucks from a sell rating to a hold rating in a research report on Thursday, August 16th. Oppenheimer lowered their price objective on shares of Starbucks from $66.00 to $61.00 and set an outperform rating on the stock in a research report on Friday, July 27th. Finally, Wedbush lowered their price objective on shares of Starbucks from $54.00 to $53.00 and set a neutral rating on the stock in a research report on Friday, July 27th. Sixteen analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. The company currently has an average rating of Hold and a consensus target price of $60.21.

Top Performing Stocks For 2021: Riverview Bancorp Inc(RVSB)

Riverview Bancorp, Inc. (Riverview), incorporated on June 23, 1997, is a savings and loan holding company of Riverview Community Bank (the Bank). The Company operates through two segments, which include banking operations performed by the Bank and trust and investment services performed by Riverview Asset Management Corp. (RAMCorp). The Company is engaged in the business of attracting deposits from the general public and using such funds in its primary market area to originate commercial business, commercial real estate, multi-family real estate, land, real estate construction, residential real estate and other consumer loans. Additionally, RAMCorp offers trust and investment services.

The Company considers Clark, Cowlitz, Klickitat and Skamania counties of Washington and Multnomah and Marion counties of Oregon as its primary market area. The Company conducts operations from its home office in Vancouver and approximately 20 branch offices located in Camas, Washougal, Stevenson, White Salmon, Battle Ground, Goldendale, Vancouver and Longview, Washington and Portland, Gresham and Aumsville, Oregon. Riverview Mortgage, a mortgage broker division of the Bank, originates mortgage loans for various mortgage companies in the Vancouver/Portland metropolitan areas, as well as for the Bank. The Bank’s Business and Professional Banking Division offers commercial and business banking services. The Bank also operates a lending office for mortgage banking activities in Vancouver.

Lending Activities

The principal lending activity of the Company is the origination of loans collateralized by commercial properties and commercial business loans. A substantial portion of the Company’s loan portfolio is secured by real estate, either as primary or secondary collateral, located in its primary market area. As of March 31, 2016, the commercial business loan portfolio totaled $69.4 million. Commercial business loans are typically secured by business equipment, accounts receivable, invent! ory or other property. As of March 31, 2016, the other real estate lending portfolio totaled $399.5 million. The Company originates other real estate loans, including office buildings, warehouse/industrial, retail, assisted living facilities and single-purpose facilities (collectively commercial real estate loans), as well as land and multi-family loans primarily located in its market area.

The Company originates three types of residential construction loans: speculative construction loans; custom/presold construction loans, and construction/permanent loans. The Company also originates construction loans for the development of business properties and multi-family dwellings. All of the Company’s real estate construction loans are made on properties located in Washington and Oregon. Speculative construction loans are made to home builders. The largest speculative construction loan at March 31, 2016 was a loan to finance the construction of a single family home totaling $261,000. Presold construction loans are made to homebuilders who, at the time of construction, have a signed contract with a home buyer having a commitment for permanent financing for the finished home from the Company or another lender. As of March 31, 2016, presold construction loans totaled $5 million. The custom construction loans are made directly to the homeowner.

The Company provides construction financing for non-residential business properties and multi-family dwellings. As of March 31, 2016, such loans totaled $16.7 million. The consumer loans totaled $129.2 million at March 31, 2016, consisting of $67.6 million of one-to four-family mortgage loans, $18.8 million of home equity lines of credit, $2.4 million of land loans to consumers for the future construction of one-to four-family homes and $40.4 million of other secured and unsecured consumer loans, which primarily consisted of purchased automobile loans. The Company also offers balloon mortgage loans. As of March 31, 2016, the Company had three resid! ential re! al estate loans totaling $251,000. The Company originates a range of installment loans, including loans for debt consolidation and other purposes, automobile loans, boat loans and savings account loans.

Investment Activities

The Company invests in the United States Treasury obligations, securities of various federal agencies, bank-qualified municipal bonds, certain certificates of deposit of insured banks, certain certificates of deposit of insured banks, repurchase agreements, federal funds and mortgage-backed securities (MBS). Its real estate mortgage investment conduits (REMICS) consist of Federal Home Loan Mortgage Company (FHLMC) and Fannie Mae (FNMA) securities and its commercial real estate (CRE) mortgage-backed securities consist of FNMA securities. As of March 31, 2016, the Company’s investment portfolio totaled $150.76 million. The Company’s investment securities available-for-sale totaled $150.69 million at March 31, 2016.

Sources of Funds

Deposits, loan repayments and loan sales are the major sources of the Company’s funds for lending and other investment purposes. Borrowings may be used on a short-term basis to compensate for reductions in the availability of funds from other sources. It may also be used on a longer-term basis for general business purposes. The Company attracts deposits from within its primary market area by offering a selection of deposit instruments, including demand deposits, negotiable order of withdrawal (NOW) accounts, money market accounts, regular savings accounts, certificates of deposit and retirement savings plans.

The Company’s deposit accounts totaled $779.8 million at March 31, 2016. The Company had $27.1 million in Certificate of Deposit Account Registry Service (CDARS) and Insured Cash Sweep (ICS) deposits. As of March 31, 2016, deposits from RAMCorp totaled $4.9 million. As of March 31, 2016, the Company also had $15.5 million in deposits from public entities located in the States of Washingto! n and Ore! gon.

Subsidiary Activities

The Bank’s subsidiaries include Riverview Services, Inc. and RAMCorp. Riverview Services acts as a trustee for deeds of trust on mortgage loans granted by the Bank and receives a reconveyance fee for each deed of trust. RAMCorp is an asset management company providing trust, estate planning and investment management services.

Advisors’ Opinion:

  • [By Logan Wallace]

    Riverview Bancorp (NASDAQ:RVSB) and Western New England Bancorp (NASDAQ:WNEB) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

  • [By Ethan Ryder]

    Fj Capital Management LLC disclosed that they own 5.6% of Riverview Bancorp Inc (NASDAQ:RVSB) in a Form 13G disclosure that was filed with the Securities and Exchange Commission (SEC) on Thursday, May 24th. The investor owns 1,273,912 shares of the stock valued at approximately $10,981,121. The reporting parties listed on the disclosure included Financial Opportunity Fund LLC, Financial Opportunity Long/Short Fund LLC, FJ Capital Management LLC and Martin S Friedman. The disclosure is available through EDGAR at this link.

Top Performing Stocks For 2021: Meridian Interstate Bancorp Inc.(EBSB)

Meridian Interstate Bancorp, Inc. operates as a holding company for East Boston Savings Bank that provides various financial services to consumers and businesses in Massachusetts. The company offers various deposit products, including non-interest-bearing demand deposits comprising checking accounts; interest-bearing demand accounts, such as NOW and money market accounts; savings accounts; and certificates of deposit, as well as commercial checking accounts. It also provides various loan products, which include commercial real estate loans, one to four family residential loans, multi-family real estate loans, construction loans, home equity lines of credit, commercial business loans, and consumer loans, as well as involves in the purchase and sale of loan participation interests. In addition, the company offers non-deposit products consisting of mutual funds, annuities, stocks, and bonds through a third party broker-dealer; and long-term care insurance through a third-part y insurance company. It operates 21 full-service locations and 2 loan centers in the greater Boston metropolitan area. The company was founded in 1848 and is based in East Boston, Massachusetts. Meridian Interstate Bancorp, Inc. is a subsidiary of Meridian Financial Services, Incorporated.

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Meridian Bancorp (EBSB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Meridian Bancorp (NASDAQ:EBSB) was upgraded by equities research analysts at BidaskClub from a “sell” rating to a “hold” rating in a report released on Saturday.

Top Performing Stocks For 2021: Valeant Pharmaceuticals International Inc(VRX)

Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. It offers Wellbutrin XL to treat depressive disorders; Xenazine to treat chorea associated with Huntington?s disease; CeraVe to rebuild and repair skin barrier; and Kinerase, a cosmetic product. The company also provides Zovirax ointment to treat initial genital herpes; Xerese to treat recurrent herpes labialis; Elidel to treat atopic dermatitis; and Acanya and Atralin gels to treat acne vulgaris. In addition, it offers Cesamet to treat nausea and vomiting associated with cancer chemotherapy; Tiazac XC to treat hypertension and angina; Wellbutrin to treat depressive illness; Sublinox to treat insomnia; and Lodalis to treat hypercholesterolemia. Further, the company provides Cold-FX to strengthen immune system; Duromine/Metermine for weight loss; Difflam to treat sore throa ts; and Duro-Tuss and Rikodeine to treat dry and chesty cough, as well as various branded generics for treatments, including antibiotics, treatments for cardiovascular and neurological diseases, antifungal medications, and diabetic therapies. Additionally, it offers Bisocard to treat hypertension and angina pectoris; Flucinar, a corticosteroid ointment; and Sachol mouth ulcer gel; Bedoyecta to treat neurotic pain; M.V.I., a hospital dietary supplement for trauma and burns; Tandene to treat fever and headache; Melleril to treat anxiety and depression; and products for therapeutic classes, such as vitamin deficiency, antibacterials, and dermatology. It markets its products in the United States, Canada, Australia, New Zealand, Europe, Latin America, southeast Asia, and South Africa. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company was founded in 1960 and is headquartered in M ississauga, Canada.

Advisors’ Opinion:

  • [By Chris Lange]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) has a PDUFA action date set for October 5 for its Jemdel (halobetasol propionate 0.01%) (IDP-122) lotion. If approved, Jemdel will be the first high-potency topical steroid treatment for plaque psoriasis with dosing for as long as eight weeks.

  • [By Shane Hupp]

    Korea Investment CORP cut its position in shares of Valeant Pharmaceuticals (NYSE:VRX) (TSE:VRX) by 46.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 126,736 shares of the specialty pharmaceutical company’s stock after selling 109,300 shares during the quarter. Korea Investment CORP’s holdings in Valeant Pharmaceuticals were worth $2,948,000 at the end of the most recent reporting period.

Top Performing Stocks For 2021: Cavco Industries, Inc.(CVCO)

Cavco Industries, Inc., incorporated on January 14, 2003, designs and produces factory-built homes. The Company operates through two segments: factory-built housing, which includes wholesale and retail systems-built housing operations, and financial services, which includes manufactured housing consumer finance and insurance. The Company’s factory-built homes are primarily distributed through a network of independent and the Company-owned retailers, planned community operators and residential developers. The Company markets its products under the brands, including Cavco Homes, Fleetwood Homes, Palm Harbor Homes, Fairmont Homes and Chariot Eagle. The Company is also a builder of park model recreational vehicle (RVs), vacation cabins and systems-built commercial structures, as well as modular homes built primarily under the Nationwide Homes brand.

The Company’s Park model RVs are primarily used as vacation dwellings and seasonal living, and are placed in planned communities, recreational home parks and resorts. The Company produces a range of modular homes, which include single and multi-section/modular ranch-style dwellings, split-level homes, Cape Cod style homes and multi-family units. It also builds commercial modular structures, including apartment buildings, condominiums, hotels, workforce housing, schools and housing for the United States military troops. The commercial projects are engineered to the purchaser’s specifications. It produces its residential homes in a range of floor plans.

Factory-built Housing

The Company constructs its homes using an assembly line process, in which each module or floor section is assembled in stages. The Company operates over 20 manufacturing facilities in Millersburg and Woodburn, Oregon; Nampa, Idaho; Riverside, California; Phoenix and Goodyear, Arizona; Austin, Fort Worth, Seguin and Waco, Texas; Montevideo, Minnesota; Nappanee, Indiana; Lafayette, Tennessee; Martinsville and Rocky Mount, Virginia; Douglas, Georgia, and O! cala and Plant City, Florida. As of April 2, 2016, the Company had a total of 45 Company-owned retail centers, located in Oregon, Arizona, New Mexico, Texas, Oklahoma, Louisiana, Virginia, North Carolina and Florida. The Company has a network of independent distribution points in approximately 40 states, Canada, Japan and Mexico. The principal materials used in the production of its manufactured homes include wood, wood products, steel, aluminum, gypsum wallboard, windows, doors, fiberglass insulation, carpet, vinyl, fasteners, plumbing materials, appliances and electrical items.

Financial Services

The Company provides a source of home buyer financing to its customers. The Company’s subsidiary, CountryPlace, is a mortgage-backed securities issuer and offers conforming mortgages, non-conforming mortgages and chattel loans to purchasers of factory-built and site-built homes. It offers mortgages to the purchasers of factory-built homes sold by the Company-owned retail sales centers and certain independent retailers, builders, communities and developers. CountryPlace originates single-family residential mortgages and chattel loans, and services, for itself and others, conforming mortgages, non-conforming land-home mortgages and manufactured home chattel loans. CountryPlace also provides loan origination and servicing functions for non-affiliated entities under contract. CountryPlace has loan contracts secured by factory-built homes located in approximately 30 states, including Texas, Florida, New Mexico, Arizona and Alabama. The Company’s insurance subsidiary, Standard Casualty Co. (Standard Casualty), provides property and casualty insurance to owners of manufactured homes. Standard Casualty specializes in homeowner property and casualty insurance products for the manufactured housing industry. In addition to writing direct policies, Standard Casualty assumes and cedes reinsurance in the ordinary course of business.

The Company competes with Clayton Homes, Inc., Champ! ion Home ! Builders, Inc., Skyline Corporation, Berkshire Hathaway, Inc., Triad Finance Corporation, CU Factory Built Lending, LP, National Lloyds and Columbia Lloyds.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Cavco Industries Inc  (NASDAQ:CVCO)Q3 2019 Earnings Conference CallFeb. 05, 2019, 8:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Cavco Industries (NASDAQ:CVCO) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Top Performing Stocks For 2021: Knowles Corporation(KN)

Knowles Corporation designs, manufactures, and sells micro-acoustic, audio processing, and specialty component solutions to the mobile consumer electronics, communications, medical, military, aerospace, and industrial markets worldwide. The company operates in two segments, Mobile Consumer Electronics and Specialty Components. The Mobile Consumer Electronics segment designs and manufactures acoustic products, including microphones and audio processing technologies for mobile handsets, tablets, and other consumer electronic devices. This segment also offers analog and digital microphones, micro-electro-mechanical systems microphones, surface mounted device microphones, receivers, speakers, integrated modules, multi-functional devices, ultrasonic sensors, voice processors, and integrated audio sub-systems. The Specialty Components segment designs and manufactures electronic components used in medical and life science applications; and solutions and components used in communications infrastructure and various other markets. This segment also provides transducer products used primarily in hearing aid applications in the commercial audiology markets; oscillator products primarily for the telecom infrastructure market; and capacitor products used in various applications, such as radio, radar, satellite, power supplies, transceivers, and medical implants for the defense, aerospace, telecommunication, and life sciences markets. The company sells its products to original equipment manufacturers; and to its contract manufacturers and suppliers, as well as through distributors. Knowles Corporation was incorporated in 2013 and is headquartered in Itasca, Illinois.

Advisors’ Opinion:

  • [By Motley Fool Transcribing]

    KnowlesCorporation (NYSE:KN) Q1 2019 Earnings CallApril 24, 2019 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    Knowles Corp (NYSE:KN) insider Michael S. Polacek bought 926 shares of the company’s stock in a transaction on Monday, March 4th. The shares were bought at an average price of $16.28 per share, for a total transaction of $15,075.28. Following the transaction, the insider now owns 84,305 shares of the company’s stock, valued at $1,372,485.40. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Top Performing Stocks For 2021: Neuberger Berman Real Estate Securities Income Fund, Inc.(NRO)

Neuberger Berman Real Estate Securities Income Fund Inc. (the Fund) is a non-diversified, closed-end management investment company. The Fund seeks to provide current income with capital appreciation as a secondary objective. The Fund invests a significant portion of its assets in securities issued by real estate companies, including real estate investment trusts (REITs). Its investment manager and administrator is Neuberger Berman Management Inc.

The Fund’s investments are concentrated in common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by companies deriving the majority of their revenue from the ownership, construction, financing, management and/or sale of commercial, industrial and/or residential real estate. The Fund invests in sectors, such as apartments, commercial services, community centers, freestanding, healthcare, industrial, lodging, manufactured homes, office, regional malls and self storage.

Advisors’ Opinion:

  • [By Ethan Ryder]

    WARNING: “Short Interest in Neuberger Berman Real Estate Sec Inc Fd (NRO) Expands By 130.1%” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international copyright law. The legal version of this report can be viewed at https://www.tickerreport.com/banking-finance/4216938/short-interest-in-neuberger-berman-real-estate-sec-inc-fd-nro-expands-by-130-1.html.

  • [By Logan Wallace]

    Neuro (CURRENCY:NRO) traded down 13.5% against the dollar during the 1 day period ending at 23:00 PM ET on October 2nd. Over the last seven days, Neuro has traded 28.9% lower against the dollar. Neuro has a market cap of $26,648.00 and approximately $49.00 worth of Neuro was traded on exchanges in the last 24 hours. One Neuro coin can currently be purchased for about $0.0005 or 0.00000007 BTC on cryptocurrency exchanges.

Top 10 Warren Buffett Stocks To Buy Right Now

Warren Buffett may not have supported Donald Trump’s candidacy for president, but the 86-year-old billionaire certainly benefited from the unexpected outcome.

Stocks are up across the board since the presidential election, boosting the value of Berkshire Hathaway’s (NYSE:BRK-A) (NYSE:BRK-B) stock portfolio, but few stocks have rallied as much as Bank of America (NYSE:BAC).

The Bank of America building dominates the Dallas skyline. Image source: Getty Images.

In 2011, during the darkest days of Bank of America’s struggle to survive the fallout from the financial crisis, Buffett called the bank’s CEO Brian Moynihan with an idea. Buffett would inject $5 billion of Berkshire Hathaway’s cash into Bank of America, giving the bank a much-needed seal of approval.

But the deal had to be done on highly favorable terms to Berkshire Hathaway. Buffett demanded $5 billion worth of preferred stock yielding 6%, or $300 million a year. On top of that, the bank kicked in warrants to buy 700 million shares of Bank of America stock for $7.14 per share, exercisable at any time before the middle of 2021.

Top 10 Warren Buffett Stocks To Buy Right Now: Brown Forman Corporation(BF.B)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Brown-Forman (BF.B)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Brown-Forman (BF.B)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Garrett Baldwin]

    Now, here’s a closer look at today’s Money Morning insight, the most important market events, and stocks to watch.

    The Top Stock Market Stories for Thursday
    Investors are eyeing news that the U.S. deficit with China hit a 10-year high during December. This widening deficit occurred even in the face of U.S. President Donald Trump’s large tariffs on Chinese goods. Trump has been slapping tariffs on China to reduce this deficit. However, Americans continued to buy cheap manufactured goods while the Chinese government has scooped up cheap commodities and raw materials from other nations. Yesterday, shares of Brown-Forman Corp. (NYSE: BF.B), the manufacturer of Jack Daniel’s whiskey, fell 7% after announcing the tariffs were hurting sales. Now, new tensions in the trade deal are emerging as the Chinese tech firm Huawei has sued the U.S. government over a ban to sell its equipment to the United States.
    Before the bell, the European Central Bank planned to announce its latest decision on interest rates and other monetary policy matters. The ECB Bank Chief Mario Draghi hosted a press conference to discuss the bank’s forecast for the European economy. Many analysts project that several key markets – like Germany – have seen a cooldown in economic activity in recent months. The ECB has never raised interest rates during any part of Draghi’s eight-year term. The 2020 election is heating up around one issue – but it’s not the one that you think. In fact, Money Morning Special Situation Strategist Tim Melvin projects that President Trump will do something shocking before the election: legalize cannabis across the United States. Think that’s crazy? Well, you’d be amazed at how easy it would be. You’ll also be shocked by how much money you could make by getting out in front of this trend – check out Tim’s latest insight right here.
    Stocks to Watch Today: KR, AMZN, PEP
    Amazon.com Inc. (NASDAQ: AMZN) has learned that brick-and-mortar retail is di

  • [By Ethan Ryder]

    Brown-Forman Co. Class B (NYSE:BF.B) issued an update on its FY19 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $1.75-1.85 for the period, compared to the Thomson Reuters consensus estimate of $1.83. The company issued revenue guidance of $3.44-3.48 billion (+6-7%), compared to the consensus revenue estimate of $3.46 billion.

  • [By Money Morning Staff Reports]

    Brown Forman Corp. (NYSE: BF.B), the makers of Jack Daniels whiskey and Woodford Reserve bourbon, surged 1,830% over the last 30 years.

    Wynn Resorts Ltd. (NASDAQ: WYNN), the famous Las Vegas casino operation, popped 913% since 2002.

Top 10 Warren Buffett Stocks To Buy Right Now: Riverview Bancorp Inc(RVSB)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Fj Capital Management LLC disclosed that they own 5.6% of Riverview Bancorp Inc (NASDAQ:RVSB) in a Form 13G disclosure that was filed with the Securities and Exchange Commission (SEC) on Thursday, May 24th. The investor owns 1,273,912 shares of the stock valued at approximately $10,981,121. The reporting parties listed on the disclosure included Financial Opportunity Fund LLC, Financial Opportunity Long/Short Fund LLC, FJ Capital Management LLC and Martin S Friedman. The disclosure is available through EDGAR at this link.

  • [By Stephan Byrd]

    Charter Financial (NASDAQ: CHFN) and Riverview Bancorp (NASDAQ:RVSB) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

  • [By Logan Wallace]

    Riverview Bancorp (NASDAQ:RVSB) and Western New England Bancorp (NASDAQ:WNEB) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Top 10 Warren Buffett Stocks To Buy Right Now: Lifeway Foods, Inc.(LWAY)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Lifeway Foods, Inc. (NASDAQ:LWAY) COO Edward Smolyansky sold 4,890 shares of the company’s stock in a transaction that occurred on Monday, June 11th. The shares were sold at an average price of $6.41, for a total value of $31,344.90. Following the sale, the chief operating officer now owns 993,614 shares in the company, valued at approximately $6,369,065.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

  • [By Logan Wallace]

    Lifeway Foods (NASDAQ:LWAY) was downgraded by equities research analysts at TheStreet from a “c-” rating to a “d” rating in a report released on Friday.

Top 10 Warren Buffett Stocks To Buy Right Now: Richmont Mines, Inc.(RIC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Riecoin (CURRENCY:RIC) traded flat against the U.S. dollar during the 1-day period ending at 23:00 PM E.T. on September 16th. Over the last week, Riecoin has traded flat against the U.S. dollar. One Riecoin coin can now be purchased for about $0.0070 or 0.00000093 BTC on major exchanges. Riecoin has a market capitalization of $308,472.00 and $0.00 worth of Riecoin was traded on exchanges in the last day.

  • [By Stephan Byrd]

    Richoux Group (LON:RIC) announced its earnings results on Tuesday. The company reported GBX (3.90) (($0.05)) earnings per share for the quarter, Bloomberg Earnings reports. Richoux Group had a negative net margin of 19.84% and a negative return on equity of 38.45%.

  • [By Stephan Byrd]

    Media headlines about Richmont Mines (NYSE:RIC) (TSE:RIC) have been trending somewhat positive this week, Accern reports. The research firm ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Richmont Mines earned a coverage optimism score of 0.03 on Accern’s scale. Accern also gave media headlines about the basic materials company an impact score of 45.3472842725256 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 Warren Buffett Stocks To Buy Right Now: Anavex Life Sciences Corp.(AVXL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Anavex Life Sciences (NASDAQ:AVXL)’s share price shot up 4.8% during mid-day trading on Tuesday . The company traded as high as $4.35 and last traded at $3.93. 14,995 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 606,708 shares. The stock had previously closed at $4.13.

  • [By Stephan Byrd]

    Schwab Charles Investment Management Inc. lifted its stake in Anavex Life Sciences Corp (NASDAQ:AVXL) by 48.8% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 76,200 shares of the biotechnology company’s stock after purchasing an additional 25,000 shares during the period. Schwab Charles Investment Management Inc.’s holdings in Anavex Life Sciences were worth $211,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Medpace (NASDAQ: MEDP) and Anavex Life Sciences (NASDAQ:AVXL) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, valuation, risk, dividends and analyst recommendations.

  • [By Joseph Griffin]

    News coverage about Anavex Life Sciences (NASDAQ:AVXL) has been trending somewhat positive on Wednesday, according to Accern. The research firm identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Anavex Life Sciences earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned headlines about the biotechnology company an impact score of 46.5362495493017 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Shane Hupp]

    Here are some of the media stories that may have effected Accern’s analysis:

    Get Anavex Life Sciences alerts:

    Comparing Anavex Life Sciences (AVXL) & Viralytics (VRACY) (americanbankingnews.com) Hot Move to Watch Anavex Life Sciences Corp. (AVXL) (nasdaqplace.com) Anavex Life Sciences (AVXL) and Intrexon (XON) Head to Head Review (americanbankingnews.com) -$0.10 EPS Expected for Anavex Life Sciences (AVXL) This Quarter (americanbankingnews.com)

    A number of equities analysts recently issued reports on the stock. Maxim Group reaffirmed a “buy” rating and set a $7.00 target price (up previously from $5.00) on shares of Anavex Life Sciences in a research report on Thursday, May 31st. Zacks Investment Research lowered shares of Anavex Life Sciences from a “buy” rating to a “hold” rating in a research report on Friday, March 23rd. Noble Financial set a $7.00 target price on shares of Anavex Life Sciences and gave the stock a “buy” rating in a research report on Wednesday, May 16th. HC Wainwright assumed coverage on shares of Anavex Life Sciences in a research report on Wednesday, May 30th. They set a “buy” rating and a $10.00 target price on the stock. Finally, Roth Capital initiated coverage on shares of Anavex Life Sciences in a research report on Thursday, March 8th. They set a “buy” rating and a $6.00 target price on the stock. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. Anavex Life Sciences presently has an average rating of “Buy” and an average target price of $6.55.

  • [By Joseph Griffin]

    Anavex Life Sciences (NASDAQ:AVXL) and Icon (NASDAQ:ICLR) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, profitability and earnings.

Top 10 Warren Buffett Stocks To Buy Right Now: Blue Buffalo Pet Products, Inc.(BUFF)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Petmed Express and pet stock peer Central Garden & Pet Co (NASDAQ: CENT) being outstanding performers over the last year or two while pet food stocks Blue Buffalo Pet Products Inc (NASDAQ: BUFF) and Freshpet Inc (NASDAQ: FRPT) have not yet lived up to investor expectations:

  • [By Shane Hupp]

    Nestlé (OTCMKTS: NSRGY) and Blue Buffalo Pet Products (NASDAQ:BUFF) are both consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

  • [By ]

    Despite his deal hunger, Hayes said he is unlikely to shock investors with an outrageous purchase. In other words, nothing in the mold of cereal giant General Mills (GIS) buying natural pet food brand Blue Buffalo (BUFF) .

Top 10 Warren Buffett Stocks To Buy Right Now: General Moly, Inc(GMO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on General Moly (GMO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Warren Buffett Stocks To Buy Right Now: Cellcom Israel Ltd.(CEL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Natural Health Trends Corp (NASDAQ: NHTC) fell 7.8 percent to $19.80 in pre-market trading after rising 1.46 percent on Friday.
    Endocyte, Inc. (NASDAQ: ECYT) shares fell 6.6 percent to $11.41 in pre-market trading after climbing 4.18 percent on Friday.
    Quorum Health Corporation (NYSE: QHC) shares fell 6.2 percent to $5.15 in pre-market trading after tumbling 11.45 percent on Friday.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) fell 6.1 percent to $7.31 in pre-market trading after declining 3.35 percent on Friday.
    Boston Scientific Corporation (NYSE: BSX) fell 5.6 percent to $28.30 in pre-market trading.
    Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 5.3 percent to $6.06 in pre-market trading after gaining 2.73 percent on Friday.
    Xerox Corporation (NYSE: XRX) shares fell 5.2 percent to $28.60 in pre-market trading. Xerox terminated its transaction agreement with Fujifilm and entered into a new agreement with Carl Icahn and Darwin Deason. JP Morgan downgraded Xerox from Overweight to Neutral.
    Cellcom Israel Ltd. (NYSE: CEL) fell 5.2 percent to $7.02 in pre-market trading. Cellcom is expected to release Q1 results on May 30, 2018.
    Perrigo Company plc (NYSE: PRGO) fell 4.5 percent to $74 in pre-market trading.
    Nabriva Therapeutics plc (NASDAQ: NBRV) shares fell 4 percent to $4.66 in pre-market trading

  • [By Lisa Levin]

    Thursday afternoon, the telecommunication services shares surged 0.58 percent. Meanwhile, top gainers in the sector included Intelsat S.A. (NYSE: I), up 5 percent, and Cellcom Israel Ltd. (NYSE: CEL) up 2.5 percent.

  • [By Lisa Levin]

    Thursday afternoon, the health care shares rose 1.79 percent. Meanwhile, top gainers in the sector included Partner Communications Company Ltd. (NASDAQ: PTNR), up 8 percent, and Cellcom Israel Ltd. (NYSE: CEL) up 7 percent.

  • [By Ethan Ryder]

    Millicom (OTCMKTS: MIICF) and Cellcom Israel (NYSE:CEL) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

  • [By Ethan Ryder]

    Hellenic Telecom Organization (NYSE: CEL) and Cellcom Israel (NYSE:CEL) are both utilities companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends and analyst recommendations.

Top 10 Warren Buffett Stocks To Buy Right Now: H&R Block, Inc.(HRB)

Advisors’ Opinion:

  • [By Ethan Ryder]

    H & R Block Inc (NYSE:HRB) Director Robert A. Gerard acquired 1,000 shares of the firm’s stock in a transaction dated Friday, June 22nd. The shares were purchased at an average price of $23.18 per share, for a total transaction of $23,180.00. Following the completion of the transaction, the director now directly owns 148,579 shares in the company, valued at $3,444,061.22. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage gain ahead of the close was H&R Block, Inc. (NYSE: HRB) which traded up about 4% at $27.40. The stock’s 52-week range is $22.45 to $29.81. Volume was 4 million compared to the daily average volume of 3.3 million.

  • [By Stephan Byrd]

    H&R Block (NYSE:HRB) saw some unusual options trading on Monday. Stock traders purchased 13,239 call options on the company. This represents an increase of approximately 1,694% compared to the average daily volume of 738 call options.

  • [By Chris Lange]

    H&R Block, Inc. (NYSE: HRB) released fiscal fourth quarter financial results after markets closed Tuesday. The company reported $5.43 in earnings per share (EPS) and $2.39 billion in revenue compared with consensus estimates that called for $5.27 in EPS and $2.34 billion in revenue. The same period last year had $3.76 in EPS and $2.33 billion in revenue.

  • [By Ethan Ryder]

    ValuEngine lowered shares of H & R Block (NYSE:HRB) from a sell rating to a strong sell rating in a research note released on Wednesday.

    Several other equities research analysts have also commented on HRB. Morgan Stanley cut their price objective on H & R Block from $30.00 to $27.00 and set an equal weight rating for the company in a research note on Wednesday. They noted that the move was a valuation call. BMO Capital Markets cut their price objective on H & R Block from $29.00 to $25.00 and set a market perform rating for the company in a research note on Wednesday. BTIG Research reiterated a sell rating and set a $21.00 price objective on shares of H & R Block in a research note on Sunday, March 11th. Northcoast Research upgraded H & R Block from a neutral rating to a buy rating and cut their price objective for the stock from $25.02 to $24.69 in a research note on Monday, March 5th. Finally, Goldman Sachs Group assumed coverage on H & R Block in a research note on Tuesday, March 27th. They set a neutral rating and a $28.00 price objective for the company. Three analysts have rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the company. H & R Block has a consensus rating of Hold and a consensus target price of $26.21.

  • [By Logan Wallace]

    Dynamic Technology Lab Private Ltd bought a new stake in H & R Block Inc (NYSE:HRB) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 113,925 shares of the company’s stock, valued at approximately $2,595,000. H & R Block accounts for approximately 0.4% of Dynamic Technology Lab Private Ltd’s portfolio, making the stock its 24th biggest holding. Dynamic Technology Lab Private Ltd owned 0.06% of H & R Block as of its most recent filing with the Securities & Exchange Commission.

Top 10 Warren Buffett Stocks To Buy Right Now: Salesforce.com Inc(CRM)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Consumers used to have to visit a retail store to buy software. That all started to change in the early 2000s when Salesforce.com (NYSE:CRM) launched the first software-as-a-service business.

  • [By Leo Sun]

    Veeva provides cloud-based customer relationship management (CRM) services for healthcare companies. Its core products include the Veeva Vault, which tracks prescribing habits, clinical trials, and industry regulations; and the Veeva Commercial Cloud, which helps drug companies maintain customer relationships.

  • [By Trey Thoelcke]

    Salesforce.com Inc. (NYSE: CRM) EPS will show a gain of 30.7% in the next five years, if the analysts are correct, while that growth was over 24% in the past five years. The enterprise cloud computing company recently secured a deal with Apple. Salesforce shares are trading about 50% higher year to date. Watch for its report in November as well.

  • [By Stephan Byrd]

    salesforce.com (NYSE:CRM) had its price target increased by Royal Bank of Canada to $155.00 in a research report report published on Wednesday morning, The Fly reports. Royal Bank of Canada currently has an outperform rating on the CRM provider’s stock.

  • [By Shane Hupp]

    salesforce.com, inc. (NYSE:CRM) General Counsel Amy E. Weaver sold 452 shares of salesforce.com stock in a transaction dated Wednesday, May 23rd. The stock was sold at an average price of $125.95, for a total value of $56,929.40. Following the completion of the transaction, the general counsel now owns 20,718 shares of the company’s stock, valued at $2,609,432.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

  • [By Stephan Byrd]

    salesforce.com, inc. (NYSE:CRM) Chairman Marc Benioff sold 10,000 shares of the company’s stock in a transaction on Monday, February 4th. The shares were sold at an average price of $155.84, for a total value of $1,558,400.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Top Value Stocks To Own Right Now

Los Angeles Capital Management & Equity Research Inc. reduced its position in shares of Aaron’s, Inc. (NYSE:AAN) by 17.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 44,145 shares of the company’s stock after selling 9,300 shares during the period. Los Angeles Capital Management & Equity Research Inc. owned 0.06% of Aaron’s worth $1,918,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Amalgamated Bank lifted its position in shares of Aaron’s by 13.5% during the second quarter. Amalgamated Bank now owns 10,222 shares of the company’s stock valued at $444,000 after purchasing an additional 1,218 shares in the last quarter. LPL Financial LLC lifted its position in shares of Aaron’s by 8.1% during the first quarter. LPL Financial LLC now owns 16,479 shares of the company’s stock valued at $768,000 after purchasing an additional 1,238 shares in the last quarter. Affinity Investment Advisors LLC lifted its position in shares of Aaron’s by 21.3% during the first quarter. Affinity Investment Advisors LLC now owns 8,318 shares of the company’s stock valued at $388,000 after purchasing an additional 1,459 shares in the last quarter. Great West Life Assurance Co. Can lifted its position in shares of Aaron’s by 5.1% during the first quarter. Great West Life Assurance Co. Can now owns 37,559 shares of the company’s stock valued at $1,751,000 after purchasing an additional 1,814 shares in the last quarter. Finally, Signaturefd LLC bought a new position in shares of Aaron’s during the first quarter valued at about $103,000.

Top Value Stocks To Own Right Now: Amgen Inc.(AMGN)

Advisors’ Opinion:

  • [By Lee Jackson]

    This biotech giant remains a top stock for investors to buy and a safe way to play the massive potential growth in biosimilars. Amgen Inc. (NASDAQ: AMGN) has been a biotechnology pioneer since 1980 and has grown to be one of the world’s leading independent biotech companies. It has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

  • [By ]

    Amgen’s (NASDAQ:AMGN) past is filled with excitement. The company rose to become one of the biggest biotechs in the world. It grew a product lineup with multiple blockbuster drugs. Over the last decade, Amgen’s share price has more than tripled. But the excitement appears likely to diminish considerably for Amgen — at least for the next few years.

  • [By Ethan Ryder]

    Wayne Hummer Investments L.L.C. trimmed its position in shares of Amgen (NASDAQ:AMGN) by 11.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,311 shares of the medical research company’s stock after selling 303 shares during the period. Wayne Hummer Investments L.L.C.’s holdings in Amgen were worth $394,000 at the end of the most recent quarter.

  • [By Dan Caplinger]

    The iShares biotech ETF has a structure that’s familiar to anyone who invests regularly in exchange-traded funds. The ETF tracks an index of nearly 200 biotech and pharmaceutical stocks, with roughly 80% of assets dedicated to true biotechs and the rest split evenly between pharma and life sciences equipment and services providers. Top ETF holdings Biogen (NASDAQ:BIIB), Amgen (NASDAQ:AMGN), and Gilead Sciences (NASDAQ:GILD) make up a total of roughly 25% of the fund’s assets.

Top Value Stocks To Own Right Now: Riverview Bancorp Inc(RVSB)

Advisors’ Opinion:

  • [By Logan Wallace]

    Riverview Bancorp (NASDAQ:RVSB) and Western New England Bancorp (NASDAQ:WNEB) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

  • [By Ethan Ryder]

    Fj Capital Management LLC disclosed that they own 5.6% of Riverview Bancorp Inc (NASDAQ:RVSB) in a Form 13G disclosure that was filed with the Securities and Exchange Commission (SEC) on Thursday, May 24th. The investor owns 1,273,912 shares of the stock valued at approximately $10,981,121. The reporting parties listed on the disclosure included Financial Opportunity Fund LLC, Financial Opportunity Long/Short Fund LLC, FJ Capital Management LLC and Martin S Friedman. The disclosure is available through EDGAR at this link.

  • [By Stephan Byrd]

    Charter Financial (NASDAQ: CHFN) and Riverview Bancorp (NASDAQ:RVSB) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

Top Value Stocks To Own Right Now: Rand Capital Corporation(RAND)

Advisors’ Opinion:

  • [By Joseph Griffin]

    TheStreet upgraded shares of Rand Capital (NASDAQ:RAND) from a d+ rating to a c rating in a research note released on Wednesday morning.

    RAND traded up $0.02 during trading on Wednesday, reaching $2.99. The company had a trading volume of 252 shares, compared to its average volume of 122,866. The company has a debt-to-equity ratio of 0.26, a quick ratio of 315.33 and a current ratio of 315.33. Rand Capital has a 12 month low of $2.05 and a 12 month high of $3.60. The firm has a market cap of $18.88 million, a P/E ratio of 100.00 and a beta of 0.05.

Top 5 Performing Stocks To Invest In Right Now

When consolidation began in the beer industry a decade ago, it was supposed to be a big win for shareholders of big beer companies. Anheuser-Busch InBev (NYSE:BUD) and Molson Coors (NYSE:TAP) now dominate overall volume in the beer industry both domestically and globally, and in theory they should be able to use their scale and distribution power to grow sales and expand margins.

But the reality in the big beer business has been very different from the theory. Market share for big beer brands is declining and pricing power is not what it once was. And big beer stocks are underperforming the market by a wide margin right now.

BUD data by YCharts

Big beer loses its luster

Overall, beer volume is falling slightly in the U.S., exemplified by a 1% drop in volume in 2017 to 196.3 million barrels, according to the Brewers Association. However, craft beer volume rose 5%, so big beer brands are losing share at a rapid rate, and conditions aren’t improving in 2018.

Top 5 Performing Stocks To Invest In Right Now: RBC Bearings Incorporated(ROLL)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    RBC Bearings (NASDAQ:ROLL) Q4 2018 Earnings Conference CallMay. 30, 2018 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Sei Investments Co. reduced its stake in RBC Bearings Incorporated (NASDAQ:ROLL) by 14.5% during the 1st quarter, Holdings Channel reports. The firm owned 31,838 shares of the industrial products company’s stock after selling 5,400 shares during the period. Sei Investments Co.’s holdings in RBC Bearings were worth $3,955,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on RBC Bearings (ROLL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    RBC Bearings Incorporated (NASDAQ:ROLL) insider Michael J. Hartnett sold 15,850 shares of the company’s stock in a transaction that occurred on Tuesday, July 3rd. The shares were sold at an average price of $128.60, for a total value of $2,038,310.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Top 5 Performing Stocks To Invest In Right Now: Scana Corporation(SCG)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage loss in the S&P 500 ahead of the close was SCANA Corp. (NYSE: SCG) which fell about 4% to $36.79. The stock’s 52-week range is $33.61 to $69.24. Volume was about 5.7 million compared to the daily average volume of 1.5 million.

  • [By Reuben Gregg Brewer]

    SCANA Corporation’s (NYSE:SCG) dividend yield is listed at an enticing 7%, but don’t get suckered in. This utility is dealing with a very troubling situation right now. You are better off sticking to a high-yield stock like utility peer Duke Energy Corporation (NYSE:DUK) and its very generous 4.9% yield. Here’s why.

  • [By Reuben Gregg Brewer]

    Investing in utilities is usually a pretty boring affair, with the main attraction normally being a reliable quarterly dividend payment. Recent events at SCANA Corporation (NYSE:SCG), however, have been anything but boring. Dominion Energy could be the company’s savior, but not if the government gets in the way.

  • [By Shane Hupp]

    Shares of SCANA Co. (NYSE:SCG) have received a consensus recommendation of “Hold” from the twelve research firms that are currently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and two have issued a buy recommendation on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $43.75.

  • [By Shane Hupp]

    These are some of the media stories that may have impacted Accern Sentiment’s analysis:

    Get NetEase alerts:

    Top 50 most innovative Chinese companies (ecns.cn) Keep an eye on Active stock of Yesterday— NetEase, Inc. (NTES) (stockmarketstop.com) Varying Stocks: DowDuPont Inc., (NYSE: DWDP), NetEase, Inc., (NASDAQ: NTES) (globalexportlines.com) Be Ready for Active Stock: NetEase, Inc. (NTES) (bitcoinpriceupdate.review) Tossing Stocks: NetEase, Inc., (NYSE: NTES), SCANA Corporation, (NYSE: SCG) (nysetradingnews.com)

    Shares of NTES opened at $267.10 on Friday. The stock has a market capitalization of $34.83 billion, a price-to-earnings ratio of 21.52, a price-to-earnings-growth ratio of 2.26 and a beta of 0.80. NetEase has a fifty-two week low of $222.32 and a fifty-two week high of $377.64.

  • [By Lisa Levin] Companies Reporting Before The Bell
    General Motors Company (NYSE: GM) is projected to report quarterly earnings at $1.24 per share on revenue of $34.66 billion.
    Bristol-Myers Squibb Company (NYSE: BMY) is estimated to report quarterly earnings at $0.85 per share on revenue of $5.24 billion.
    United Parcel Service, Inc. (NYSE: UPS) is expected to report quarterly earnings at $1.55 per share on revenue of $16.44 billion.
    Time Warner Inc. (NYSE: TWX) is projected to report quarterly earnings at $1.74 per share on revenue of $7.91 billion.
    ConocoPhillips (NYSE: COP) is expected to report quarterly earnings at $0.74 per share on revenue of $8.81 billion.
    PepsiCo, Inc. (NYSE: PEP) is expected to report quarterly earnings at $0.93 per share on revenue of $12.4 billion.
    American Airlines Group Inc. (NASDAQ: AAL) is estimated to report quarterly earnings at $0.72 per share on revenue of $10.42 billion.
    Southwest Airlines Co (NYSE: LUV) is expected to report quarterly earnings at $0.74 per share on revenue of $5.01 billion.
    Fiat Chrysler Automobiles N.V. (NYSE: FCAU) is estimated to report quarterly earnings at $0.8 per share on revenue of $34.52 billion.
    Union Pacific Corporation (NYSE: UNP) is projected to report quarterly earnings at $1.66 per share on revenue of $5.38 billion.
    D.R. Horton, Inc. (NYSE: DHI) is expected to report quarterly earnings at $0.85 per share on revenue of $3.76 billion.
    The Hershey Company (NYSE: HSY) is estimated to report quarterly earnings at $1.4 per share on revenue of $1.94 billion.
    Praxair, Inc. (NYSE: PX) is expected to report quarterly earnings at $1.56 per share on revenue of $2.94 billion.
    Altria Group, Inc. (NYSE: MO) is projected to report quarterly earnings at $0.92 per share on revenue of $4.63 billion.
    Shire plc (NASDAQ: SHPG) is estimated to report quarterly earnings at $3.54 per share on revenue of $3.72 billion.
    Oshkosh Corporation (NYSE: OSK) is projected to report quarter

Top 5 Performing Stocks To Invest In Right Now: Riverview Bancorp Inc(RVSB)

Advisors’ Opinion:

  • [By Logan Wallace]

    Riverview Bancorp (NASDAQ:RVSB) and Western New England Bancorp (NASDAQ:WNEB) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

  • [By Ethan Ryder]

    Fj Capital Management LLC disclosed that they own 5.6% of Riverview Bancorp Inc (NASDAQ:RVSB) in a Form 13G disclosure that was filed with the Securities and Exchange Commission (SEC) on Thursday, May 24th. The investor owns 1,273,912 shares of the stock valued at approximately $10,981,121. The reporting parties listed on the disclosure included Financial Opportunity Fund LLC, Financial Opportunity Long/Short Fund LLC, FJ Capital Management LLC and Martin S Friedman. The disclosure is available through EDGAR at this link.

  • [By Stephan Byrd]

    Charter Financial (NASDAQ: CHFN) and Riverview Bancorp (NASDAQ:RVSB) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

Top 5 Performing Stocks To Invest In Right Now: Norwood Financial Corp.(NWFL)

Advisors’ Opinion:

  • [By Max Byerly]

    Media headlines about Norwood Financial (NASDAQ:NWFL) have trended somewhat negative this week, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Norwood Financial earned a coverage optimism score of -0.01 on Accern’s scale. Accern also assigned news coverage about the financial services provider an impact score of 46.6420547965898 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Top 5 Performing Stocks To Invest In Right Now: Liberty Broadband Corporation(LBRDK)

Advisors’ Opinion:

  • [By Max Byerly]

    Liberty Broadband Corp Series C (NASDAQ: LBRDK) and Roku (NASDAQ:ROKU) are both consumer discretionary companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.

  • [By Stephan Byrd]

    Toronto Dominion Bank increased its stake in Liberty Broadband Corp Series C (NASDAQ:LBRDK) by 45.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,646 shares of the company’s stock after acquiring an additional 3,309 shares during the period. Toronto Dominion Bank’s holdings in Liberty Broadband Corp Series C were worth $805,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Schwab Charles Investment Management Inc. lifted its holdings in Liberty Broadband Corp Series C (NASDAQ:LBRDK) by 0.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 297,059 shares of the company’s stock after acquiring an additional 798 shares during the period. Schwab Charles Investment Management Inc. owned 0.16% of Liberty Broadband Corp Series C worth $22,494,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Liberty Broadband Corp Series C (LBRDK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Heal Care Stocks For 2019

Kroger’s (NYSE:KR) solid first-quarter results earlier this month made it clear Amazon.com isn’t slowing the grocer down, despite worries that the e-commerce giant’s acquisition of Whole Foods would take a toll on traditional grocers, Kroger’s quarterly comparable-store sales growth rates have been trending upward over the past year. And Kroger’s higher-than-expected revenue and earnings per share in its first quarter reaffirmed the company is not only holding its own but growing nicely.

Kroger’s 3.4% revenue growth, 1.4% same-store sales growth, and 26% adjusted earnings-per-share growth in its first quarter undoubtedly speak to the company’s resilience amid a changing retail landscape. But for investors who want to go a little deeper and learn about what’s going on behind the headline numbers, Kroger’s first-quarter earnings call featured some interesting takeaways.

Here are several key excerpts from Kroger’s first-quarter earnings call.

Image source: Getty Images.

Top 5 Heal Care Stocks For 2019: Nordic American Offshore Ltd(NAO)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media headlines about Nordic American Offshore (NYSE:NAO) have been trending somewhat negative on Thursday, according to Accern. Accern ranks the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Nordic American Offshore earned a media sentiment score of -0.10 on Accern’s scale. Accern also assigned headlines about the shipping company an impact score of 46.9955270541452 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Max Byerly]

    Nordic American Offshore (NYSE: NAO) and DryShips (NASDAQ:DRYS) are both small-cap transportation companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, profitability, valuation, dividends and risk.

Top 5 Heal Care Stocks For 2019: Riverview Bancorp Inc(RVSB)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Charter Financial (NASDAQ: CHFN) and Riverview Bancorp (NASDAQ:RVSB) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

  • [By Ethan Ryder]

    Fj Capital Management LLC disclosed that they own 5.6% of Riverview Bancorp Inc (NASDAQ:RVSB) in a Form 13G disclosure that was filed with the Securities and Exchange Commission (SEC) on Thursday, May 24th. The investor owns 1,273,912 shares of the stock valued at approximately $10,981,121. The reporting parties listed on the disclosure included Financial Opportunity Fund LLC, Financial Opportunity Long/Short Fund LLC, FJ Capital Management LLC and Martin S Friedman. The disclosure is available through EDGAR at this link.

  • [By Logan Wallace]

    Riverview Bancorp (NASDAQ:RVSB) and Western New England Bancorp (NASDAQ:WNEB) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Top 5 Heal Care Stocks For 2019: M&T Bank Corporation(MTB)

Advisors’ Opinion:

  • [By Logan Wallace]

    Amundi Pioneer Asset Management Inc. lifted its position in M&T Bank Co. (NYSE:MTB) by 17.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 241,374 shares of the financial services provider’s stock after buying an additional 35,785 shares during the quarter. Amundi Pioneer Asset Management Inc. owned about 0.17% of M&T Bank worth $44,499,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    IFM Investors Pty Ltd grew its stake in shares of M&T Bank (NYSE:MTB) by 9.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,289 shares of the financial services provider’s stock after buying an additional 383 shares during the period. IFM Investors Pty Ltd’s holdings in M&T Bank were worth $791,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Evercore ISI upgraded shares of M&T Bank (NYSE:MTB) from an in-line rating to an outperform rating in a report issued on Monday morning, Marketbeat reports. The analysts noted that the move was a valuation call.

  • [By Ethan Ryder]

    M&T Bank (NYSE: MTB) and S.Y. Bancorp (NASDAQ:SYBT) are both finance companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, earnings, dividends, valuation and profitability.

Top 5 Heal Care Stocks For 2019: Federal Signal Corporation(FSS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Principal Financial Group Inc. boosted its position in Federal Signal Co. (NYSE:FSS) by 2.9% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 474,038 shares of the conglomerate’s stock after purchasing an additional 13,161 shares during the period. Principal Financial Group Inc. owned about 0.79% of Federal Signal worth $10,438,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Federal Signal (FSS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Prudential Financial Inc. grew its holdings in shares of Federal Signal Co. (NYSE:FSS) by 63.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 234,061 shares of the conglomerate’s stock after purchasing an additional 90,560 shares during the period. Prudential Financial Inc.’s holdings in Federal Signal were worth $5,154,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    VOLKSWAGEN (OTCMKTS:VLKAY) and Federal Signal (NYSE:FSS) are both auto/tires/trucks companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation and earnings.

  • [By Max Byerly]

    Dimensional Fund Advisors LP decreased its stake in shares of Federal Signal Co. (NYSE:FSS) by 5.5% during the 2nd quarter, Holdings Channel reports. The firm owned 4,501,589 shares of the conglomerate’s stock after selling 263,703 shares during the period. Dimensional Fund Advisors LP owned about 0.08% of Federal Signal worth $104,842,000 as of its most recent SEC filing.

Top 5 Heal Care Stocks For 2019: Steelcase Inc.(SCS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Steelcase (SCS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Garrett Baldwin]

    After 111 years as a member of the Dow Jones Industrial Average, General Electric Co. (NYSE: GE) has been replaced on the index by Walgreens Boots Alliance Inc. (NYSE: WBA). According to David Blitzer, managing director and chair of the Index Committee at S&P Dow Jones Indices, the change is part of an effort to increase value and prominence of consumer goods, finance, healthcare, and technology firms on the U.S. economy. GE is the last original member to be removed from the index. Shares of Boeing Co. (NYSE BA), DowDuPont Inc. (NYSE: DOW), and Caterpillar Inc. (NYSE: CAT) are getting pounded on concerns that a full-blown trade war may accelerate and hurt major exporters to China. Yesterday, U.S. President Donald Trump announced he may seek tariffs on another $200 billion in Chinese goods. Trump has asked U.S. trade representatives to identify potential products on which the United States could implement a 10% tariff. Recent trade volatility has erased all gains in the Dow Jones in 2018. Walt Disney Co. (NYSE: DIS) has raised its bid for Twenty-First Century Fox Inc. (NYSE: FOXA) assets to $71.3 billion in cash and stock. The new offer tops the $35 all-cash offer proposed last week by cable and telecom giant Comcast Corp. (Nasdaq: CMCSA).
    Three Stocks to Watch Today: MU, ORCL, SBUX
    Micron Technology Inc. (Nasdaq: MU) will lead a light day of earnings reports Wednesday. The Chinese semiconductor giant is expected to report earnings per share (EPS) of $3.14 on top of $7.75 billion in revenue. While markets will be interested in this report, the greater focus will likely center on the impact of U.S. tariffs on the company’s forward guidance. Oracle Corp. (NYSE: ORCL) stock was off 3.7% despite news that the cloud computing giant topped Wall Street earnings expectations yesterday. The firm reported adjusted EPS of $0.99 on top of $11.25 billion in revenue. Those numbers beat average expectations of $0.94 on $11.18 billion. The stock slumped after

  • [By Logan Wallace]

    Steelcase Inc. (NYSE:SCS) VP James N. Ludwig sold 7,500 shares of the business’s stock in a transaction on Friday, September 28th. The shares were sold at an average price of $18.56, for a total value of $139,200.00. Following the completion of the transaction, the vice president now owns 31,960 shares of the company’s stock, valued at $593,177.60. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

  • [By Ethan Ryder]

    Peel Hunt reissued their buy rating on shares of SCS Group (LON:SCS) in a research note published on Thursday.

    SCS Group stock opened at GBX 211 ($2.75) on Thursday. SCS Group has a one year low of GBX 127.13 ($1.66) and a one year high of GBX 237 ($3.09).

  • [By Asit Sharma]

    Contemporary office environment furnisher Steelcase Inc. (NYSE:SCS) reported on its first quarter of fiscal 2019 Wednesday after the close of trading. While the company managed a better year-over-year revenue comparison than the fourth quarter of 2018, in which revenue dipped nearly 5%, top-line performance was still lukewarm at best.

Top 10 Medical Stocks To Buy For 2019

If you’re like most people getting ready to retire, you’re probably counting on Social Security benefits to cover a big portion of your living expenses. Unfortunately, many future retirees significantly underestimate how much of their Social Security check is likely to be eaten up by one big expense: healthcare. 

In fact, future retirees responding to a recent survey conducted by Nationwide significantly underestimated the percentage of their Social Security benefits likely to go toward their care as they age. 

The good news is, while costly health issues are a fact of life for many seniors, there are steps you can take to try to keep costs affordable and make sure you still have enough Social Security left to live on — even after paying for medical help. 

Image source: Getty Images.

Top 10 Medical Stocks To Buy For 2019: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Syndax Pharmaceuticals (SNDX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Jon C. Ogg]

    Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) was started with a Buy rating and assigned a $30 price target at H.C. Wainwright on July 12. This is a small $175 million market cap company at the time of the call, but the price target in this call was about 300% higher than the $7.10 closing price. Syndax has a 52-week range of $6.61 to $15.20, and its most recent closing price was $7.49. The cancer pipeline has been the focus for such large upside here, and at one point one analyst was pointing to Syndax rallying to as high as $40.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Syndax Pharmaceuticals (SNDX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) was down, falling around 21 percent to $8.76 after the company issued updated results from Phase 2 ENCORE trial of entinostat in combo with KEYTRUDA.

Top 10 Medical Stocks To Buy For 2019: Core-Mark Holding Company Inc.(CORE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Core-Mark (CORE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Rhumbline Advisers decreased its holdings in Core-Mark Holding Company, Inc. (NASDAQ:CORE) by 10.2% in the first quarter, HoldingsChannel reports. The firm owned 106,505 shares of the business services provider’s stock after selling 12,145 shares during the quarter. Rhumbline Advisers’ holdings in Core-Mark were worth $2,264,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Core-Mark (CORE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Buy For 2019: BancorpSouth, Inc.(BXS)

Advisors’ Opinion:

  • [By Max Byerly]

    QCR (NASDAQ: QCRH) and Bancorpsouth Bank (NYSE:BXS) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

  • [By Logan Wallace]

    Brean Capital reaffirmed their hold rating on shares of Bancorpsouth Bank (NYSE:BXS) in a research report released on Sunday.

    Other analysts also recently issued research reports about the stock. Zacks Investment Research upgraded shares of Bancorpsouth Bank from a hold rating to a buy rating and set a $38.00 price objective for the company in a report on Tuesday, June 19th. Stephens restated a buy rating and set a $37.00 price objective on shares of Bancorpsouth Bank in a report on Monday, August 27th. Eight investment analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average target price of $35.57.

  • [By Stephan Byrd]

    Bancorpsouth Bank (NYSE:BXS) has been given an average recommendation of “Hold” by the eleven analysts that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $35.13.

Top 10 Medical Stocks To Buy For 2019: Riverview Bancorp Inc(RVSB)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Fj Capital Management LLC disclosed that they own 5.6% of Riverview Bancorp Inc (NASDAQ:RVSB) in a Form 13G disclosure that was filed with the Securities and Exchange Commission (SEC) on Thursday, May 24th. The investor owns 1,273,912 shares of the stock valued at approximately $10,981,121. The reporting parties listed on the disclosure included Financial Opportunity Fund LLC, Financial Opportunity Long/Short Fund LLC, FJ Capital Management LLC and Martin S Friedman. The disclosure is available through EDGAR at this link.

  • [By Stephan Byrd]

    Charter Financial (NASDAQ: CHFN) and Riverview Bancorp (NASDAQ:RVSB) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

  • [By Logan Wallace]

    Riverview Bancorp (NASDAQ:RVSB) and Western New England Bancorp (NASDAQ:WNEB) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Top 10 Medical Stocks To Buy For 2019: Benchmark Electronics, Inc.(BHE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Benchmark Electronics, Inc. (NYSE:BHE) declared a quarterly dividend on Monday, September 17th, RTT News reports. Shareholders of record on Friday, September 28th will be given a dividend of 0.15 per share by the technology company on Thursday, October 11th. This represents a $0.60 annualized dividend and a yield of 2.44%. The ex-dividend date of this dividend is Thursday, September 27th.

Top 10 Medical Stocks To Buy For 2019: Willis Lease Finance Corporation(WLFC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Willis Lease Finance Co. (NASDAQ:WLFC) CEO Charles F. Iv Willis sold 4,718 shares of the firm’s stock in a transaction on Tuesday, June 26th. The shares were sold at an average price of $31.19, for a total transaction of $147,154.42. Following the sale, the chief executive officer now owns 706,058 shares in the company, valued at approximately $22,021,949.02. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

Top 10 Medical Stocks To Buy For 2019: B&G Foods, Inc.(BGS)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of B&G Foods, Inc. (NYSE:BGS) have been given a consensus rating of “Hold” by the thirteen analysts that are covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $34.67.

  • [By ]

    Cramer was bearish on BGC Partners (BGCP) , Dr Pepper Snapple (DPS) , Sterling Construction Co. Inc.  (STRL) and B&G Foods (BGS) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By ]

    B&G Foods (NYSE: BGS) – Look in your pantry or your fridge or your freezer, there’s a better than 50% chance you got a couple of this company’s brands on the shelf. This $28 billion packaged food firm has been quietly acquiring old brands and breathing new and profitable life into them. Reviving stalwarts, such as Ortega, Cream of Wheat and Green Giant, and making headway with progressive, younger brands such as Skinny Girl and Pirate’s Booty (which my 16-year-old seems to live off), the company pulled in $1.6 billion in annual revenue last year while delivering a mind-boggling 24.7% return on equity. While officially a consumer staple stock, B&G is in growth mode through acquisition as displayed through its superior ROE. Shares trade at a 31% discount to their 52-week high. The stock trades at $28 (a 31with a forward PE of 13.41 and a compelling 6.78% dividend yield.

Top 10 Medical Stocks To Buy For 2019: MEI Pharma, Inc.(MEIP)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd
  • [By Logan Wallace]

    Get a free copy of the Zacks research report on MEI Pharma (MEIP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Headlines about MEI Pharma (NASDAQ:MEIP) have been trending somewhat negative on Friday, according to Accern. Accern ranks the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. MEI Pharma earned a coverage optimism score of -0.06 on Accern’s scale. Accern also gave media stories about the company an impact score of 45.5534769772513 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Money Morning News Team]

    Seadrill’s rally demonstrates how profitable penny stocks can be for savvy investors. With Seadrill’s gains already on the books, we’ll look at a stock that’s on track to generate tremendous returns – a small cap that just completed a groundbreaking acquisition with huge profit potential…

    Penny Stock Current Share Price Law Week’s Gain
    Seadrill Ltd. (NYSE: SDRL) $0.58 98.74%
    Vivis Inc. (Nasdaq: VVUS) $0.83 59.97%
    MEI Pharma Inc. (Nasdaq: MEIP) $3.45 43.40%
    Transenterix Inc. (NYSE: TRXC) $3.15 35.72%
    Akers Biosciences Inc. (Nasdaq: AKER) $0.65 34.38%
    Galectin Therapeutics Inc. (Nasdaq: GALT) $4.54 32.58%
    Phoenix New Media Ltd. (NYSE ADR: FENG) $5.65 32.22%
    Heat Biologics Inc. (Nasdaq: HTBX) $1.73 31.37%
    Bright Scholar Education Ltd. (NYSE ADR: BEDU) $18.51 29.03%
    21 Vianet Group Inc. (Nasdaq: VNET) $7.36 28.72%

    These gains are incredibly exciting. However, not all penny stocks are equally strong investments.

  • [By Ethan Ryder]

    Shares of MEI Pharma Inc (NASDAQ:MEIP) were up 13.2% during trading on Wednesday . The company traded as high as $4.30 and last traded at $4.30. Approximately 651,334 shares were traded during trading, an increase of 127% from the average daily volume of 287,125 shares. The stock had previously closed at $3.80.

Top 10 Medical Stocks To Buy For 2019: Mallinckrodt plc(MNK)

Advisors’ Opinion:

  • [By Paul Ausick]

    Mallinckrodt PLC (NYSE: MNK) traded down about 3.5% Friday to post a new 52-week low of $11.65 after closing Thursday at $12.07. The stock’s 52-week high is $49.12. Volume was about 10% below the daily average of around 3.9 million shares. The company had no specific news.

  • [By Stephan Byrd]

    Canaccord Genuity set a $34.00 price objective on Mallinckrodt (NYSE:MNK) in a research report released on Sunday. The firm currently has a hold rating on the stock.

  • [By Stephan Byrd]

    Shares of Mallinckrodt PLC (NYSE:MNK) have been given a consensus recommendation of “Hold” by the twenty-two brokerages that are presently covering the firm, MarketBeat reports. Three analysts have rated the stock with a sell recommendation, fourteen have given a hold recommendation and five have given a buy recommendation to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $27.44.

  • [By Sean Williams]

    After running a screen for healthcare stocks with a PEG ratio below 1 (courtesy of Yahoo! Finance), the following 13 were all that remained:

    Innoviva (NASDAQ:INVA): 0.42 PEG ratio Celgene (NASDAQ:CELG): 0.54 Mallinckrodt (NYSE:MNK): 0.59 Exelixis (NASDAQ:EXEL): 0.60 Global Cord Blood Corp.: 0.72 AbbVie: 0.75 Vertex Pharmaceuticals: 0.80 DaVita: 0.80 Supernus Pharmaceuticals: 0.80 Mednax: 0.82 MiMedx Group: 0.88 CIGNA: 0.93 Medpace Holdings: 0.95

    Image source: Getty Images.

  • [By Dan Caplinger]

    Wall Street moved lower on Thursday, with the Dow Jones Industrial Average suffering a 201-point decline. Stocks took their cues from the bond market, where bond prices dropped sharply in response to extremely strong U.S. economic data. For years, the economic expansion has given bond investors a Goldilocks scenario, in which growth was solid but not so sharp as to cause negative side effects, such as inflation. Now, stronger signals could force the Federal Reserve to raise interest rates more aggressively than previously thought, and that could hurt the markets. Several individual companies also suffered from bad news that sent their shares lower. Mallinckrodt (NYSE:MNK), International Speedway (NASDAQ:ISCA), and LGI Homes (NASDAQ:LGIH) were among the worst performers on the day. Here’s why they did so poorly.

Top 10 Medical Stocks To Buy For 2019: Nuveen AMT-Free Municipal Income Fund(NEA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Wells Fargo & Company MN raised its holdings in Nuveen AMT-Free Municipal (NYSE:NEA) by 8.7% during the first quarter, HoldingsChannel reports. The institutional investor owned 4,674,452 shares of the company’s stock after buying an additional 372,370 shares during the period. Wells Fargo & Company MN’s holdings in Nuveen AMT-Free Municipal were worth $60,768,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    BB&T Securities LLC cut its holdings in Nuveen Amt-Free Quality Municpl Incm Fnd (NYSE:NEA) by 3.7% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 260,949 shares of the company’s stock after selling 10,037 shares during the quarter. BB&T Securities LLC owned about 0.10% of Nuveen Amt-Free Quality Municpl Incm Fnd worth $3,392,000 at the end of the most recent quarter.

Best Low Price Stocks To Buy For 2019

Following past boom/bust cycles, the oil business appears to have bottomed in February 2016 at $27 a barrel. The bruising multi-year bust in crude oil prices was the biggest reason for the world stock market sell-off from late 2015 to early 2016 of roughly 15% overall. The cruel irony of ultra-low prices is its disruptive effect on regular exploration activity. A short-term oil market depression in expectations disproportionately slashes oil drilling activity. Oil exploration budgets for 2017 are down 65% from 2014 and the smallest in 12 years, DESPITE a record estimate for global demand next year. In the long-run, oil & gas development and production may fail to keep pace with the steady growth in total demand. Will the 2015-16 “bust” sow the seeds of the next “boom” phase in pricing?

Click to enlarge

Best Low Price Stocks To Buy For 2019: Gibraltar Industries, Inc.(ROCK)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Schwab Charles Investment Management Inc. increased its position in shares of Gibraltar Industries Inc (NASDAQ:ROCK) by 12.2% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 219,629 shares of the construction company’s stock after buying an additional 23,911 shares during the quarter. Schwab Charles Investment Management Inc.’s holdings in Gibraltar Industries were worth $7,435,000 as of its most recent SEC filing.

Best Low Price Stocks To Buy For 2019: Care.com, Inc.(CRCM)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Care.com Inc (NYSE:CRCM) CFO Michael Echenberg sold 8,110 shares of Care.com stock in a transaction that occurred on Tuesday, June 12th. The shares were sold at an average price of $21.64, for a total transaction of $175,500.40. Following the transaction, the chief financial officer now directly owns 30,938 shares in the company, valued at approximately $669,498.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

  • [By Lisa Levin]

    Care.com, Inc. (NYSE: CRCM) shares shot up 19 percent to $18.8426 following Q1 earnings.

    Shares of ProPhase Labs, Inc. (NASDAQ: PRPH) got a boost, shooting up 54 percent to $4.4302 after the company announced a special $1.00 per share cash dividend.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Care.com (CRCM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Low Price Stocks To Buy For 2019: Noodles & Company(NDLS)

Advisors’ Opinion:

  • [By Max Byerly]

    Noodles & Company (NASDAQ:NDLS) is scheduled to be posting its quarterly earnings results after the market closes on Thursday, May 10th. Analysts expect Noodles & Company to post earnings of ($0.03) per share for the quarter. Noodles & Company has set its FY18 guidance at $(0.01)-0.03 EPS.

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Dan Caplinger]

    The stock market finished mixed on Friday, with the Dow Jones Industrial Average gaining ground even as some broader benchmarks finished closer to unchanged for the day. In the absence of major news, investors seemed content to let positive trends from earlier in the week continue to play out, anticipating a favorable end to the first-quarter earnings season and hoping for more progress on the macroeconomic and geopolitical fronts to defuse potential controversies. Some good reports from several corners of the market also helped lift sentiment. The Trade Desk (NASDAQ:TTD), Noodles & Co. (NASDAQ:NDLS), and Regeneron Pharmaceuticals (NASDAQ:REGN) were among the best performers on the day. Here’s why they did so well.

Best Low Price Stocks To Buy For 2019: Riverview Bancorp Inc(RVSB)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Charter Financial (NASDAQ: CHFN) and Riverview Bancorp (NASDAQ:RVSB) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

  • [By Ethan Ryder]

    Fj Capital Management LLC disclosed that they own 5.6% of Riverview Bancorp Inc (NASDAQ:RVSB) in a Form 13G disclosure that was filed with the Securities and Exchange Commission (SEC) on Thursday, May 24th. The investor owns 1,273,912 shares of the stock valued at approximately $10,981,121. The reporting parties listed on the disclosure included Financial Opportunity Fund LLC, Financial Opportunity Long/Short Fund LLC, FJ Capital Management LLC and Martin S Friedman. The disclosure is available through EDGAR at this link.

Best Low Price Stocks To Buy For 2019: InnerWorkings, Inc.(INWK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Total System Services (NYSE: TSS) and InnerWorkings (NASDAQ:INWK) are both business services companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, valuation, dividends and earnings.

  • [By Joseph Griffin]

    Shares of InnerWorkings, Inc. (NASDAQ:INWK) have been assigned an average recommendation of “Hold” from the six ratings firms that are presently covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell rating and three have given a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $14.00.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on InnerWorkings (INWK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Casino Stocks To Own Right Now

Steve Wynn is the biggest shareholder of the casino company that bears his name, and he’s transformed Las Vegas with trailblazing projects. That doesn’t make him invincible.

#lazy-img-323224254:before{padding-top:66.75%;}

Steve Wynn

Photographer: Calvin Sit/Bloomberg

Casino regulators have the authority to force him out of the industry over allegations that he sexually harassed female employees for years at his resorts, according to former officials and legal experts.

“Nevada regulators have a broad range of options when it comes to potential disciplining of a licensee,” AG Burnett, former chairman of the Nevada Gaming Control Board, the state’s top regulatory body, said in an interview. “These include things like complaints, fines, and even potentially revocation.”

Best Casino Stocks To Own Right Now: Energy Select Sector SPDR ETF (XLE)

Advisors’ Opinion:

  • [By Jim Crumly]

    Crude oil surged over $70 a barrel after the announcement that the U.S. will exit the Iran nuclear deal. TheEnergy Select Sector SPDR ETF (NYSEMKT:XLE) jumped 2%. Interest on 10-year Treasurys broke through the 3% level, boosting financial shares, with theFinancial Select Sector SPDR ETF (NYSEMKT:XLF) closing up 1.5%.

  • [By ]

    When we compare the energy sectors recent run to the S&P 500, its not even close. The Energy Select Sector SPDR (NYSE:XLE) has jumped more than 20% since Sept. 1. The S&P is up a little more than 10% over the same timeframe.

  • [By Jim Crumly]

    Energy stocks fell on lower oil prices, but transportation stocks gained. TheEnergy Select Sector SPDR ETF (NYSEMKT:XLE) dropped 1.6%, and theiShares Transportation Average ETF (NYSEMKT:IYT) rose 1.1%.

  • [By Logan Wallace]

    Colonial Trust Advisors decreased its holdings in Energy Select Sector SPDR (NYSEARCA:XLE) by 23.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,094 shares of the exchange traded fund’s stock after selling 1,266 shares during the period. Colonial Trust Advisors’ holdings in Energy Select Sector SPDR were worth $276,000 as of its most recent SEC filing.

  • [By Chris Johnson]

    Yesterday, I recommended SPDR Energy Select Sector ETF (NYSE Arca: XLE) shares as one of the “Best in Breed,” a screaming buy according to my proprietary system.

Best Casino Stocks To Own Right Now: Regal Entertainment Group(RGC)

Advisors’ Opinion:

  • [By Peter Graham]

    In December, UK based Cineworld Group Plc also agreed tobuy larger U.S. peer Regal Entertainment Group (NYSE: RGC) for $3.6 billion in cash in adeal to create the world’s second largest movie theatre operator after AMC Entertainment Holdings. The combined entity is expected to be better able to compete AMC.

Best Casino Stocks To Own Right Now: Riverview Bancorp Inc(RVSB)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Fj Capital Management LLC disclosed that they own 5.6% of Riverview Bancorp Inc (NASDAQ:RVSB) in a Form 13G disclosure that was filed with the Securities and Exchange Commission (SEC) on Thursday, May 24th. The investor owns 1,273,912 shares of the stock valued at approximately $10,981,121. The reporting parties listed on the disclosure included Financial Opportunity Fund LLC, Financial Opportunity Long/Short Fund LLC, FJ Capital Management LLC and Martin S Friedman. The disclosure is available through EDGAR at this link.